Haemophagocytic lymphohistiocytosis in a patient with left ventricular assist device

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Left ventricular assist devices provide circulatory support to heart failure patients while awaiting a suitable donor heart. However, with their increased duration of therapy, complications are seen frequently. Although coagulation disorders (bleeding and thrombosis) are the most common complications, infection is also a major complication associated with significant morbidity. We report a case of a 53-year-old male with a left ventricular assist device who presented with driveline infection. He subsequently developed pancytopenia and was diagnosed with haemophagocytosis. Immediate treatment with intravenous immunoglobulin and methylprednisolone was started. His blood cell count returned to normal levels and the patient became eligible for heart transplantation again. Our case represents the rare occurrence of haemophagocytosis in a patient, which, if unnoticed, could lead to fatal consequences.

Cite

CITATION STYLE

APA

Ergi, D. G., Dorken Gallastegi, A., Arslan, E., & Kahraman, Ü. (2021). Haemophagocytic lymphohistiocytosis in a patient with left ventricular assist device. European Journal of Cardio-Thoracic Surgery, 60(3), 717–718. https://doi.org/10.1093/ejcts/ezab102

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free